Media Centre

Herzog Fox & Neeman Represented Foamix Pharmaceuticals Ltd. in Its First Prospectus as a Domestic U.S. Filer

8 April 2018

Herzog Fox & Neeman represented Foamix Pharmaceuticals Ltd., an Israeli bio-tech company, as they successfully filed their first prospectus as a domestic U.S. filer. This SEC filling of a shelf registration statement on Form S-3 in an amount of up to $291 million.

Search by +